Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic α-Cells*
暂无分享,去创建一个
[1] M. Ravier,et al. Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic α-Cells , 2005 .
[2] P. Cryer,et al. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. , 2005, Diabetes.
[3] James D. Johnson,et al. Reduced Expression of the Insulin Receptor in Mouse Insulinoma (MIN6) Cells Reveals Multiple Roles of Insulin Signaling in Gene Expression, Proliferation, Insulin Content, and Secretion* , 2005, Journal of Biological Chemistry.
[4] J. Carvalheira,et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway , 2005, Diabetologia.
[5] M. White,et al. Signaling Pathways: The Benefits of Good Communication , 2004, Current Biology.
[6] Catherine B. Chan,et al. Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression* , 2004, Journal of Biological Chemistry.
[7] Xiaosong Ma,et al. ATP-Sensitive K+ Channel–Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1−/− Mouse α-Cells , 2004 .
[8] A. Poeppl,et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] S Del Prato,et al. Beta- and Alpha-Cell Dysfunction in Type 2 Diabetes , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[10] N. Kobayashi,et al. Adenovirus Mediated Gene Transduction of Primarily Isolated Mouse Islets , 2004, ASAIO journal.
[11] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[12] Johan Auwerx,et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.
[13] C. Newgard,et al. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. , 2004, Diabetes.
[14] J. Agudo,et al. In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors. , 2004, Human gene therapy.
[15] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[16] L. Gawenis,et al. A domain mimic increases DeltaF508 CFTR trafficking and restores cAMP-stimulated anion secretion in cystic fibrosis epithelia. , 2004, American journal of physiology. Cell physiology.
[17] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[18] R. Robertson,et al. Regulation of α-Cell Function by the β-Cell in Isolated Human and Rat Islets Deprived of Glucose: the “Switch-off” Hypothesis , 2004 .
[19] R. Robertson,et al. Regulation of α-Cell Function by the β-Cell During Hypoglycemia in Wistar Rats: the “Switch-off” Hypothesis , 2004 .
[20] K. Yoshimoto,et al. Differentiation phenotypes of pancreatic islet β- and α-cells are closely related with homeotic genes and a group of differentially expressed genes , 2004 .
[21] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[22] P. Rorsman,et al. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. , 2004, Diabetes.
[23] F. Ashcroft,et al. Type 2 diabetes mellitus: not quite exciting enough? , 2004, Human molecular genetics.
[24] G. Rutter,et al. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. , 2004, The Biochemical journal.
[25] C. Kahn,et al. Insulin receptor knockout mice. , 2003, Annual review of physiology.
[26] S. Ryu,et al. Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway* , 2003, Journal of Biological Chemistry.
[27] Y. Moriyama,et al. Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in αTC6 Cells, Mouse Clonal α-Cells, and α-Cells of Islets of Langerhans , 2003 .
[28] S. Schreiber,et al. Integration of growth factor and nutrient signaling: implications for cancer biology. , 2003, Molecular cell.
[29] C. Wollheim,et al. Islet β-cell secretion determines glucagon release from neighbouring α-cells , 2003, Nature Cell Biology.
[30] M. White,et al. c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* , 2003, The Journal of Biological Chemistry.
[31] N. Kimura,et al. A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[32] D. Accili,et al. Mouse models of insulin resistance. , 2004, American journal of physiology. Endocrinology and metabolism.
[33] Catherine B. Chan,et al. Inhibition of Kv2.1 Voltage-dependent K+Channels in Pancreatic β-Cells Enhances Glucose-dependent Insulin Secretion* , 2002, The Journal of Biological Chemistry.
[34] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[35] D. Gilot,et al. PI3K‐FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival , 2002, Hepatology.
[36] G. Thomas,et al. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. , 2002, Genes & development.
[37] Kirk W. Johnson,et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. , 2002, Diabetes.
[38] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[39] B. Meyer,et al. Haemochromatosis mutations and ferritin in myocardial infarction: a case‐control study , 2002, European journal of clinical investigation.
[40] P. Cryer,et al. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. , 2002, Diabetes.
[41] G. Thomas. The S6 kinase signaling pathway in the control of development and growth. , 2002, Biological research.
[42] Graeme I. Bell,et al. Diabetes mellitus and genetically programmed defects in β-cell function , 2001, Nature.
[43] A. Jaeschke,et al. Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.
[44] Hong Wu,et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[46] J W Yates,et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.
[47] L. Terracciano,et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. , 2000, Science.
[48] Roger Davis,et al. The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.
[49] H. Edlund,et al. Pancreas: how to get there from the gut? , 1999, Current opinion in cell biology.
[50] P. MacDonald,et al. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. , 1999, Diabetes.
[51] S. Gammeltoft,et al. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction , 1999, Molecular and Cellular Endocrinology.
[52] P. Cohen,et al. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[53] B. Kemp,et al. Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.
[54] H. Berman,et al. Metabolic engineering with recombinant adenoviruses. , 1999, Annual review of nutrition.
[55] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[56] M. Kitamura,et al. Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.
[57] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[58] L. Dekker,et al. Activation of PRK1 by Phosphatidylinositol 4,5-Bisphosphate and Phosphatidylinositol 3,4,5-Trisphosphate , 1995, The Journal of Biological Chemistry.
[59] S. Kahn,et al. The key role of islet dysfunction in type II diabetes mellitus. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.
[60] B. Gabrielli,et al. A cardiolipin-activated protein kinase from rat liver structurally distinct from the protein kinases C. , 1994, The Journal of biological chemistry.
[61] D. Hanahan,et al. Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. , 1993, Development.
[62] W. Tamborlane,et al. Loss of Potentiating Effect of Hypoglycemia on the Glucagon Response to Hyperaminoacidemia in IDDM , 1993, Diabetes.
[63] D. Drucker,et al. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene. , 1992, The Journal of biological chemistry.
[64] C. Greenbaum,et al. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. , 1991, The Journal of clinical investigation.
[65] K. Hamaguchi,et al. Comparison of Cytokine Effects on Mouse Pancreatic α-Cell and β-Cell Lines Viability, Secretory Function, and MHC Antigen Expression , 1990, Diabetes.
[66] P. Rorsman,et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels , 1989, Nature.
[67] V. Marks,et al. The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas. , 1988, The Journal of clinical investigation.
[68] L. Orci,et al. Insulin within islets is a physiologic glucagon release inhibitor. , 1984, The Journal of clinical investigation.
[69] P. Brunetti,et al. Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion , 1983, Diabetes.
[70] S. Friesen. Tumors of the endocrine pancreas. , 1982, The New England journal of medicine.
[71] J. Palmer,et al. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. , 1981, The Journal of clinical investigation.
[72] R. Rizza,et al. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. , 1980, Metabolism: clinical and experimental.
[73] L Orci,et al. Endocrine pancreas: three-dimensional reconstruction shows two types of islets of langerhans. , 1979, Science.
[74] P. Raskin,et al. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. , 1975, The Journal of clinical investigation.
[75] J. Gerich,et al. Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.